ArticleEuropean heart journal2017
Utilization and in-hospital complications of cardiac resynchronization therapy: trends in the United States from 2003 to 2013.
Article in European heart journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 53 citations in OpenAlex.
- Impact of sex on the utilization of defibrillation-capable cardiac implantable devices and outcome: results from the German device registry.Clinical research in cardiology : official journal of the German Cardiac Society · 2026Article
- Leadless Devices: the Future of Pacing.Current cardiology reports · 2025Review
- Cardiac implantable electronic device upgrades and downgrades: a Clinical Consensus Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Asia Pacific Heart Rhythm Association (APHRS), Canadian Heart Rhythm Society (CHRS), Heart Rhythm Society (HRS), and the Latin American Heart Rhythm Society (LAHRS).Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025Article
- Atrial Fibrillation Catheter Ablation among Cancer Patients: Utilization Trends and In-Hospital Outcomes.Journal of clinical medicine · 2024Article
- Single- Versus Dual-Chamber Implantable Cardioverter-Defibrillator for Primary Prevention of Sudden Cardiac Death in the United States.Journal of the American Heart Association · 2023Article
- Inter-American Society of Cardiology (CIFACAH-ELECTROSIAC) and Latin-American Heart Rhythm Society (LAHRS): multidisciplinary review on the appropriate use of implantable cardiodefibrillator in heart failure with reduced ejection fraction.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2023Article
- Trends in the Use and Complications of Cardiac Resynchronization Therapy Device Implantation in Chronic Kidney Disease Patients.The Journal of innovations in cardiac rhythm management · 2023Article
- Interamerican Society of Cardiology (CIFACAH - ELECTROSIAC)/Latin American Heart Rhythm Society (LAHRS): multidisciplinary review on the appropriate use of cardiac resynchronization therapy in heart failure.Archivos de cardiologia de Mexico · 2023Article
- Assessment of freely available online videos of cardiac electrophysiological procedures from a shared decision-making perspective.Cardiovascular digital health journal · 2022Article
- Guideline-directed device therapies in heart failure: A clinical practice-based analysis using electronic health record data.American heart journal plus : cardiology research and practice · 2022Article
- The Obesity Paradox in Real-World Nation-Wide Cohort of Patients Admitted for a Stroke in the U.S.Journal of clinical medicine · 2022Article
- Implantation of cardiac electronic devices in active COVID-19 patients: Results from an international survey.Heart rhythm · 2022Article
- 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2022Article
- Impact of Comorbidity Burden on Cardiac Implantable Electronic Devices Outcomes.Clinical Medicine Insights. Cardiology · 2022Article
- Sex difference and outcome trends following transcatheter aortic valve replacement.Frontiers in cardiovascular medicine · 2022Article
- Device runtime and costs of cardiac resynchronization therapy pacemakers - a health claims data analysis.German medical science : GMS e-journal · 2022Article
- The Relationship Between Body Mass Index and In-hospital Survival in Patients Admitted With Acute Heart Failure.Frontiers in cardiovascular medicine · 2022Article
- Judgement of the multidisciplinary team is an important predictor of mortality after cardiac resynchronization therapy.ESC heart failure · 2021Article
- The relationship between the body mass index and in-hospital mortality in patients admitted for sudden cardiac death in the United States.Clinical cardiology · 2021Article
- Impact of Guidelines on the Diffusion of Medical Technology: A Case Study of Cardiac Resynchronization Therapy in the UK.Applied health economics and health policy · 2021Article
Corrections and comments
- Commented on by
Authors and funding
8 authors at 2 institutions in 1 country.
Funding
Abstract
Aims: Cardiac resynchronization therapy (CRT) device implantation has been shown to reduce morbidity and mortality in selected patients with heart failure. We sought to investigate the utilization and in-hospital complications of cardiac resynchronization therapy defibrillator (CRT-D) and pacemaker (CRT-P) implantations in the United States from 2003 to 2013. Methods and results: Patients receiving CRT-D or CRT-P were identified in the National Inpatient Sample database (NIS), using the International Classification of Diseases-Ninth Revision-Clinical Modification procedure codes. Annual implantation rates, patient demographics, co-morbidities, in-hospital complications, and length of stay were analysed. From 2003 to 2013, an estimated total of 439 010 (95% CI: 406 723-471 296) inpatient CRT implantations were performed in the U.S. The median age of patients was 72 and 71% were male. Overall, 6.1% had at least one complication. During the study period, comorbidity index and overall complication rate increased (P = 0.002 and P = 0.01, respectively). Mortality and length of stay showed no significant trend. Predictors of complications included: age 65 and older, female sex (OR: 1.19; 95% CI: 1.12-1.27), Deyo-Charlson Comorbidity Index, and elective admission (OR: 0.61; 95% CI: 0.57-0.66). Conclusion: From 2003 to 2013, the severity of comorbid conditions increased and a rising trend was observed in the rate of periprocedural complications among patients undergoing CRT in the United States. In-hospital mortality and length of stay showed no uniform trend.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.